NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
Clinical Trials
56 trialsNCT04948463 2025-12-24
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
NCT07205536 2025-12-11
ANC-IIT-004
Affiliated Hospital of Nantong University
Phase 2 Recruiting
NCT07016165 2025-08-22
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Gadjah Mada University
Phase 4 Recruiting
NCT06657183 2025-08-12
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT06500715 2025-05-16
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Shaare Zedek Medical Center
Phase NA Not yet recruiting
NCT04637464 2025-04-09
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT06665737 2025-01-28
G-CSF in NHL
Department of Medical Services Ministry of Public Health of Thailand
Phase 4 Not yet recruiting
NCT06794320 2025-01-27
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
The University of Hong Kong
Phase NA Not yet recruiting
NCT04260230 2024-12-30
REACT
The Christie NHS Foundation Trust
Phase NA Withdrawn
NCT05584930 2024-12-30
CluPPFeN
University Hospital, Angers
Phase NA Completed
NCT03233776 2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2 Completed
NCT04099901 2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2 Completed
NCT06616571 2024-09-27
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Qilu Pharmaceutical Co., Ltd.
Phase 4 Recruiting
NCT05784844 2024-09-19
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
Phase 4 Withdrawn
NCT06293677 2024-07-11
DAR-ARC
Centre Hospitalier Universitaire Vaudois
Phase 4 Recruiting
NCT06450821 2024-06-10
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
University of Leeds
Phase NA Not yet recruiting
NCT06278896 2024-02-26
END
Brigham and Women's Hospital
Phase 3 Not yet recruiting
NCT06143735 2023-11-22
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT06116734 2023-11-03
Lapelga vs Gastrofil
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Unknown
NCT03104595 2023-08-15
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Enzychem Lifesciences Corporation
Phase 1/2 Completed
NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
NCT04477616 2023-02-23
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT05393505 2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4 Unknown
NCT02728596 2022-10-20
TrACER
SWOG Cancer Research Network
Phase NA Completed
NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
NCT03429387 2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA Completed
NCT03087227 2022-05-09
NEUTROSIS
University of Paris 13
Phase NA Completed
NCT04466137 2022-02-09
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 3 Completed
NCT05206006 2022-01-25
ANTIBIONEED
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT05133310 2022-01-04
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase 4 Unknown
NCT04758442 2021-02-17
Hemato-Vanco
Ciusss de L'Est de l'Île de Montréal
Phase NA Unknown
NCT02685111 2020-07-31
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Asan Medical Center
Phase 2 Terminated
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT00536081 2019-11-06
Various G-CSF Regimens to Prevent Infection During Chemotherapy
Academisch Ziekenhuis Maastricht
Phase 3 Completed
NCT04000711 2019-06-27
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
Hospital Infantil de Mexico Federico Gomez
Phase NA Completed
NCT03003273 2019-02-01
DALFEN
All India Institute of Medical Sciences
Phase 3 Terminated
NCT02544685 2019-01-17
FENSY
S&D Pharma SK s.r.o.
Phase 2 Unknown
NCT03793205 2019-01-07
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
Peking Union Medical College Hospital
Phase 4 Unknown
NCT03740464 2018-11-14
Long-acting G-CSF for Febrile Neutropenia
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02005458 2018-07-17
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 2 Completed
NCT03449693 2018-03-05
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia
Universidad Nacional Autonoma de Mexico
Phase 2 Unknown
NCT00911170 2017-12-29
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
Phase 3 Completed
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT01569087 2016-12-05
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Biocad
Phase 2 Completed
NCT02104830 2016-10-24
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Biocad
Phase 3 Completed
NCT01222819 2016-04-06
G-CSF
Rabin Medical Center
Phase 4 Terminated
NCT02463747 2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT02119715 2014-04-22
A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT00982540 2014-01-29
Dindexval
Universidade Federal do Rio de Janeiro
Phase NA Terminated